Callow M J, Stoltzfus L J, Lawn R M, Rubin E M
Life Sciences Division, Lawrence Berkeley Laboratory, University of California, Berkeley 94720.
Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2130-4. doi: 10.1073/pnas.91.6.2130.
The atherogenic macromolecule lipoprotein(a) [Lp(a)] has resisted in vivo analyses partly because it is found in a limited number of experimental animals. Although transgenic mice expressing human apolipoprotein (a) [apo(a)] have previously been described, they failed to assemble Lp(a) particles because of the inability of human apo(a) to associate with mouse apolipoprotein B (apoB). We isolated a 90-kilobase P1 phagemid containing the human apoB gene and with this DNA generated 13 lines of transgenic mice of which 11 expressed human apoB. The human apoB transcript was expressed and edited in the liver of the transgenic mice. Plasma concentrations of human apoB, as well as low density lipoprotein (LDL), were related to transgene copy number; the transgenic line with the most copies of human apoB had a > 4-fold increase in LDL cholesterol compared with nontransgenics and a lipoprotein profile similar to that of humans. When human apoB and apo(a) transgenic mice were bred together, plasma apo(a) in mice expressing both human proteins was tightly associated with lipoproteins in the LDL density region. These studies demonstrate the successful expression of human apoB and the efficient assembly of Lp(a) in mice.
致动脉粥样硬化大分子脂蛋白(a)[Lp(a)]难以进行体内分析,部分原因是它仅在有限数量的实验动物中存在。尽管此前已描述了表达人载脂蛋白(a)[apo(a)]的转基因小鼠,但由于人apo(a)无法与小鼠载脂蛋白B(apoB)结合,它们未能组装出Lp(a)颗粒。我们分离出一个包含人apoB基因的90千碱基P1噬菌粒,并利用该DNA培育出13株转基因小鼠品系,其中11株表达人apoB。人apoB转录本在转基因小鼠肝脏中表达并经过编辑。人apoB以及低密度脂蛋白(LDL)的血浆浓度与转基因拷贝数相关;人apoB拷贝数最多的转基因品系与非转基因小鼠相比,LDL胆固醇增加了4倍以上,且脂蛋白谱与人相似。当将人apoB和apo(a)转基因小鼠杂交时,同时表达这两种人类蛋白的小鼠血浆中的apo(a)与LDL密度区域的脂蛋白紧密结合。这些研究证明了人apoB在小鼠中的成功表达以及Lp(a)在小鼠中的有效组装。